MARKET

CODX

CODX

Co-Diagnostics Inc
NASDAQ
0.4689
-0.0784
-14.32%
Pre Market: 0.4789 +0.01 +2.13% 08:01 10/28 EDT
OPEN
0.5415
PREV CLOSE
0.5473
HIGH
0.5550
LOW
0.4520
VOLUME
4.83K
TURNOVER
581.22K
52 WEEK HIGH
46.50
52 WEEK LOW
0.4520
MARKET CAP
4.14M
P/E (TTM)
-0.0197
1D
5D
1M
3M
1Y
5Y
1D
'Congo Ebola Cases Top 10,000 as Violence Hits Health Workers' - Bloomberg
Benzinga · 1d ago
EXCLUSIVE: Co-Diagnostics Moves Closer to Commercial Tuberculosis Test Launch in India
Benzinga · 1d ago
Co-Diagnostics JV completes study of CoSara PCR MTB test, submits for clearance
TipRanks · 1d ago
Co-Diagnostics's India JV CoSara Diagnostics Completes Its Clinical Performance Study Of The CoSara PCR Mycobacterium Tuberculosis Test On CoSara PCR Pro Instrument; Has Submitted Test To India's Central Drugs Standard Control Organization For Regulatory Clearance
Benzinga · 1d ago
Co-Diagnostics' Joint Venture CoSara Diagnostics Completes Clinical Study and Regulatory Submission for Point-of-Care Tuberculosis Test, Sets Stage for Commercial Launch in India
PR Newswire · 1d ago
Weekly Report: what happened at CODX last week (1019-1023)?
Weekly Report · 2d ago
Co-Diagnostics' Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
PR Newswire · 10/20 13:15
Weekly Report: what happened at CODX last week (1012-1016)?
Weekly Report · 10/19 09:57
More
About CODX
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.

Webull offers Co-Diagnostics Inc stock information, including NASDAQ: CODX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CODX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CODX stock methods without spending real money on the virtual paper trading platform.